The EU retail investment package aims to strengthen the legislative framework to ensure that retail investors are empowered to take more informed investment decisions that better correspond to their needs and objectives, and are adequately protected in the single market by a coherent regulatory framework.
In this opinion, the EESC supports the Commission and the upcoming Belgian Presidency's commitment to safeguard digital inclusion for all. Member States should be encouraged to focus on equal access to digital education and training and digital tools, amongst which by ensuring access for learners and teachers with disabilities, eliminating urban-rural and other geographical divides and eliminating bias in algorithms. Action by social partners and CSOs aimed at improving digital skills, eliminating digital exclusion and closing the digital gap in society should be supported by improved access to EU and national funding. This opinion points at the need to provide teachers with a broader access to high-quality and relevant continuous professional development on digital skills and competences and to tackle teacher shortages.
Improving Micro Small and Medium Enterprises’ (MSMEs) financial resilience is crucial to avoid unnecessary bankruptcies, loss of jobs and mitigate the impact of the past, ongoing and future crisis.
The 2030 Agenda for Sustainable Development, adopted by all United Nations Member States in 2015, provides a shared blueprint for peace and prosperity for people and the planet, now and into the future. At its heart are the 17 Sustainable Development Goals (SDGs), which are an urgent call for action by all developed and developing countries in a global partnership. They recognize that ending poverty and other deprivations must go hand-in-hand with strategies that improve health and education, reduce inequality, and spur economic growth – all while tackling climate change and working to preserve our oceans and forests.
The Commission is proposing an ambitious revision of the EU pharmaceutical legislation (including a Directive and a Regulation), in order to, inter alia, create a Single Market for medicines, ensure an innovation-friendly framework for research and production and reduce the administrative burden.